.pharmacy

The generic top-level domain (gTLD) .pharmacy was launched by the National Association of Boards of Pharmacy (NABP) in 2014 "to provide consumers around the world a means for identifying safe, legal, and ethical online pharmacies and related resources". A review by the NABP of more than 10,800 websites selling prescription drugs "found that nearly 97% do not follow pharmacy laws and standards established to protect the public health".^[1]

The impartiality of the domain has been questioned, because Eli Lilly and Company, Merck & Co., and Pfizer are the main contributors to the NABP application. Previously, that application was challenged by Public Citizen, Knowledge Ecology International, and the Canadian International Pharmacy Association.^[2]

References

↑ NABP Launches .Pharmacy Generic Top-Level Domain to Help Consumers Find Safe Pharmacies Online Archived 2016-09-20 at the Wayback Machine—National Association of Boards of Pharmacy (September 9, 2014)
↑ Can The Dot Pharmacy New Generic Domain Be Impartial?—Intellectual Property Watch (July 7, 2014)

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] NABP Launches .Pharmacy Generic Top-Level Domain to Help Consumers Find Safe Pharmacies Online Archived 2016-09-20 at the Wayback Machine—National Association of Boards of Pharmacy (September 9, 2014)

[2] Can The Dot Pharmacy New Generic Domain Be Impartial?—Intellectual Property Watch (July 7, 2014)

[1]

[2]